A new non-melanoma skin cancer (NMSC) treatment is being trialled in Australia for efficacy and comfort, quality of life and cosmetic outcomes for patients.
“Australia has the highest incidence of NMSCs in the world, so it is imperative that we investigate new treatment options and continue to improve patient outcomes,” Siddhartha Baxi, a researcher of the study, said.
